Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2013; 19(38): 6416-6426
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6416
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6416
Primary | Host | Dilution dose | Company | Secondary | Dilution dose | Company |
HuC/D | Mouse | 1:500 | Molecular Probes, Invitrogen | Anti-mouse Alexa Fluor 488 | 1:500 | Molecular probes, Invitrogen |
nNOS | Rabbit | 1:500 | Zymed | Anti-rabbit Alexa Fluor 546 | 1:500 | Molecular probes, Invitrogen |
S-100 | Rabbit | 1:500 | Molecular Probes, Invitrogen | Anti-rabbit Alexa Fluor 546 | 1:500 | Molecular probes, Invitrogen |
VIP | Rabbit | 1:500 | Península Laboratories, Inc. | Anti-rabbit Alexa Fluor 546 | 1:500 | Molecular probes, Invitrogen |
- Citation: Ferreira PEB, Lopes CRP, Alves AMP, Alves &PB, Linden DR, Zanoni JN, Buttow NC. Diabetic neuropathy: An evaluation of the use of quercetin in the cecum of rats. World J Gastroenterol 2013; 19(38): 6416-6426
- URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6416.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6416